Dear Ronald and Peter
Thanks a lot for your comments.
Regulatory professionals reading this forum are aware, I agree.
But as we all know, sometimes management is looking at the bottom line and are not always on board in getting some projects done in an expedited manner since this costs money.
The links may provide for some RA individuals, the arguments to use to convince management.
The number of existing MDR certificates is a drop in the bucket so I believe that many issues have led to this state of affairs and that this is not strictly related to the notified bodies and competent authorities having inadequate communication with the manufacturers.
The whole system has to be really re-thought i.e. expedited process for legacy devices with sufficient high quality evidence. Right now, these devices receive a MDR certificate after the Technical File has been submitted 12-18 months later.
In addition, what is the ecological footprint of re-reviewing these devices in such detail? A lot of talk about saving the environment in Brussels ("Green Plan"), but the regulatory process should also be within the analysis.
Looking at the numbers of MDR certificates granted, the EU may have a dramatic shortage in medical devices next year and in the years to come. This will not only impact EU but also countries outside the EU and drive up prices since the EU will try to acquire the medical devices in short supply outside the EU. We may all be affected.
Hope to see you at RAPS Convergence in Montreal to discuss further,
Stephanie
------------------------------
Stephanie Grassmann
Founder & Managing Director of MedTechXperts Ltd
Biberstein
Switzerland
------------------------------
Original Message:
Sent: 14-Aug-2023 03:11
From: Ronald Boumans
Subject: New MDR Transition Timelines and Notified Body Capacity - Team NB Position Paper
I fully agree with Stephanie; you must immediately start working on getting an application for MDR certification filed with a notified body. This also implies that you must be ready for that certification process.
I think most regulatory professionals reading this forum are well aware about the urgency of this process and I expect their companies to be ahead of the game. The problem is for all those organizations that haven't been reached by this message. How on earth will we get them to understand their time is running out quickly...?
------------------------------
Ronald Boumans
MDR Expert
Super PRRC
Netherlands
Original Message:
Sent: 13-Aug-2023 04:38
From: Stephanie Grassmann
Subject: New MDR Transition Timelines and Notified Body Capacity - Team NB Position Paper
Dear Community
The following Team NB Position Paper and NB Survey on Certifications and Applications is being posted:
(i) to outline the stumbling blocks that the notified bodies face
(ii) to show the enormous number of MDR applications still to be submitted (possible dramatic situation in 2024) and also
(ii) to give those in the RA department further supporting arguments to enable the expedition of the MDR application submission.
https://www.team-nb.org/wp-content/uploads/2023/08/Team-NB-PositionPaper-MDRTransitionTimelines-NotifiedBodyCapacity-V1.pdf
Notified Bodies Survey on Certifications and Applications (MDR/ IVDR)
https://health.ec.europa.eu/system/files/2023-07/md_nb_survey_certifications_applications_en.pdf
Take-aways:
- Number of MDR certificates issued to this timepoint is a drop in the bucket.
- Average timeframe between MDR application submitted and written agreement signed is 2-3 months
- NBs still do not have sufficient resources
o 208 MDR applications refused by NBs in March 2023 since outside of scope
o 31 MDR applications refused due to in insufficient NB resources
-> More efficient use of resources -> proposing an expedited process for legacy devices e.g. those whose design is described in textbooks and their use are stated as safe and efficient in which sufficient evidence already exists. Other proposals are in the Team NB Position Paper.
All these MDCGs should really be integrated into a revised MDR. If this process was performed, the lawmakers in Brussels would better understand the complaints of users: i.e. MDCG text not always being aligned with the MDR or existing legislation (national/ regional) and they in some case are extending and expanding the work scope of the manufacturer.
Please do not leave MDR application submission to 2024 based on the "state of affairs".
Best Regards,
Stephanie
------------------------------
Stephanie Grassmann
Founder & Managing Director of MedTechXperts Ltd
Biberstein
Switzerland
------------------------------